Treatment with Myr reduced the expression of pro-apoptotic Bax, and increased expression of the anti-apoptotic Bcl-2, indicating that inhibition of cardiac cell apoptosis may be one of pivotal mechanisms by which Myr attenuates DCM. This evidence concerns the gene BCL2 and familial dilated cardiomyopathy.